Advertisement
Screener

REGENXBIO Inc. (RGNX) Other Comprehensive Income (Loss), Net of Tax

1.9 / 5 stars · 38/99 Roast Me

REGENXBIO Inc. Other Comprehensive Income (Loss), Net of Tax

REGENXBIO Inc. (RGNX) reported Other Comprehensive Income (Loss), Net of Tax of -$5.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06

  • REGENXBIO Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$5.00K, a 141.67% decline year-over-year.
  • REGENXBIO Inc. other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$183.00K.
  • REGENXBIO Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was -$35.00K.
  • REGENXBIO Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $98.00K, a 94.18% decline year-over-year.
  • REGENXBIO Inc. other comprehensive income (loss), net of tax for fiscal 2025 was $54.00K, a 98.54% decline from fiscal 2024.
  • REGENXBIO Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $3.69M, a 66.39% decline from fiscal 2023.
  • REGENXBIO Inc. other comprehensive income (loss), net of tax for fiscal 2023 was $10.97M.
  • REGENXBIO Inc. other comprehensive income (loss), net of tax for fiscal 2022 was -$12.83M.
Period endOther Comprehensive Income (Loss), Net of Tax 3 monthOther Comprehensive Income (Loss), Net of Tax 6 monthOther Comprehensive Income (Loss), Net of Tax 9 monthOther Comprehensive Income (Loss), Net of Tax 12 month
2026-06-30-$5.00K
10-Q · filed 2026-08-06
-$188.00K
10-Q · filed 2026-08-06
-$223.00K
derived: sum of 3 quarters · filed 2026-08-06
-$125.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$183.00K
10-Q · filed 2026-05-14
-$218.00K
derived: sum of 2 quarters · filed 2026-05-14
-$120.00K
derived: sum of 3 quarters · filed 2026-05-14
-$108.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$35.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$63.00K
derived: sum of 2 quarters · filed 2026-03-05
$75.00K
derived: sum of 3 quarters · filed 2026-08-06
$54.00K
10-K · filed 2026-03-05
2025-09-30$98.00K
10-Q · filed 2025-11-06
$110.00K
derived: sum of 2 quarters · filed 2026-08-06
$89.00K
10-Q · filed 2025-11-06
-$70.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$12.00K
10-Q · filed 2026-08-06
-$9.00K
10-Q · filed 2026-08-06
-$168.00K
derived: sum of 3 quarters · filed 2026-08-06
$1.52M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$21.00K
10-Q · filed 2026-05-14
-$180.00K
derived: sum of 2 quarters · filed 2026-05-14
$1.50M
derived: sum of 3 quarters · filed 2026-05-14
$2.47M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$159.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$1.52M
derived: sum of 2 quarters · filed 2026-03-05
$2.49M
derived: sum of 3 quarters · filed 2026-03-05
$3.69M
10-K · filed 2026-03-05
2024-09-30$1.68M
10-Q · filed 2025-11-06
$2.65M
derived: sum of 2 quarters · filed 2025-11-06
$3.85M
10-Q · filed 2025-11-06
$6.83M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$963.00K
10-Q · filed 2025-08-07
$2.16M
10-Q · filed 2025-08-07
$5.15M
derived: sum of 3 quarters · filed 2025-08-07
$7.83M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$1.20M
10-Q · filed 2025-05-12
$4.18M
derived: sum of 2 quarters · filed 2025-05-12
$6.87M
derived: sum of 3 quarters · filed 2025-05-12
$8.39M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$2.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
$5.67M
derived: sum of 2 quarters · filed 2025-03-13
$7.19M
derived: sum of 3 quarters · filed 2025-03-13
$10.97M
10-K · filed 2025-03-13
2023-09-30$2.69M
10-Q · filed 2024-11-06
$4.21M
derived: sum of 2 quarters · filed 2024-11-06
$7.99M
10-Q · filed 2024-11-06
$10.84M
derived: sum of 4 quarters · filed 2025-03-13
2023-06-30$1.52M
10-Q · filed 2024-08-01
$5.30M
10-Q · filed 2024-08-01
$8.16M
derived: sum of 3 quarters · filed 2025-03-13
$4.67M
derived: sum of 4 quarters · filed 2025-03-13
2023-03-31$3.78M
10-Q · filed 2024-05-08
$6.63M
derived: sum of 2 quarters · filed 2025-03-13
$3.14M
derived: sum of 3 quarters · filed 2025-03-13
$328.00K
derived: sum of 4 quarters · filed 2025-03-13
2022-12-31$2.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13
-$638.00K
derived: sum of 2 quarters · filed 2025-03-13
-$3.45M
derived: sum of 3 quarters · filed 2025-03-13
-$12.83M
10-K · filed 2025-03-13
2022-09-30-$3.49M
10-Q · filed 2023-11-08
-$6.31M
derived: sum of 2 quarters · filed 2023-11-08
-$15.69M
10-Q · filed 2023-11-08
-$16.97M
derived: sum of 4 quarters · filed 2024-02-27
2022-06-30-$2.81M
10-Q · filed 2023-08-02
-$12.19M
10-Q · filed 2023-08-02
-$13.48M
derived: sum of 3 quarters · filed 2024-02-27
-$13.51M
derived: sum of 4 quarters · filed 2024-02-27
2022-03-31-$9.38M
10-Q · filed 2023-05-03
-$10.66M
derived: sum of 2 quarters · filed 2024-02-27
-$10.70M
derived: sum of 3 quarters · filed 2024-02-27
-$10.58M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31-$1.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
-$1.31M
derived: sum of 2 quarters · filed 2024-02-27
-$1.20M
derived: sum of 3 quarters · filed 2024-02-27
-$2.21M
10-K · filed 2024-02-27
2021-09-30-$30.00K
10-Q · filed 2022-11-03
$83.00K
derived: sum of 2 quarters · filed 2022-11-03
-$925.00K
10-Q · filed 2022-11-03
-$1.55M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$113.00K
10-Q · filed 2022-08-03
-$895.00K
10-Q · filed 2022-08-03
-$1.52M
derived: sum of 3 quarters · filed 2023-02-28
-$2.00M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$1.01M
10-Q · filed 2022-05-04
-$1.63M
derived: sum of 2 quarters · filed 2023-02-28
-$2.12M
derived: sum of 3 quarters · filed 2023-02-28
-$788.00K
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$623.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$1.11M
derived: sum of 2 quarters · filed 2023-02-28
$220.00K
derived: sum of 3 quarters · filed 2023-02-28
-$565.00K
10-K · filed 2023-02-28
2020-09-30-$487.00K
10-Q · filed 2021-11-02
$843.00K
derived: sum of 2 quarters · filed 2021-11-02
$58.00K
10-Q · filed 2021-11-02
-$100.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$1.33M
10-Q · filed 2021-08-09
$545.00K
10-Q · filed 2021-08-09
$387.00K
derived: sum of 3 quarters · filed 2022-03-01
$279.00K
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31-$785.00K
10-Q · filed 2021-05-05
-$943.00K
derived: sum of 2 quarters · filed 2022-03-01
-$1.05M
derived: sum of 3 quarters · filed 2022-03-01
-$521.00K
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31-$158.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
-$266.00K
derived: sum of 2 quarters · filed 2022-03-01
$264.00K
derived: sum of 3 quarters · filed 2022-03-01
$885.00K
10-K · filed 2022-03-01
2019-09-30-$108.00K
10-Q · filed 2020-11-04
$422.00K
derived: sum of 2 quarters · filed 2020-11-04
$1.04M
10-Q · filed 2020-11-04
$1.20M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$530.00K
10-Q · filed 2020-08-06
$1.15M
10-Q · filed 2020-08-06
$1.30M
derived: sum of 3 quarters · filed 2021-03-01
$1.20M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$621.00K
10-Q · filed 2020-05-07
$775.00K
derived: sum of 2 quarters · filed 2021-03-01
$672.00K
derived: sum of 3 quarters · filed 2021-03-01
$804.00K
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$154.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$51.00K
derived: sum of 2 quarters · filed 2021-03-01
$183.00K
derived: sum of 3 quarters · filed 2021-03-01
-$5.00K
10-K · filed 2021-03-01
2018-09-30-$103.00K
10-Q · filed 2019-11-05
$29.00K
derived: sum of 2 quarters · filed 2019-11-05
-$159.00K
10-Q · filed 2019-11-05
-$320.00K
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30$132.00K
10-Q · filed 2019-08-07
-$56.00K
10-Q · filed 2019-08-07
-$217.00K
derived: sum of 3 quarters · filed 2020-02-26
-$124.00K
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31-$188.00K
10-Q · filed 2019-05-07
-$349.00K
derived: sum of 2 quarters · filed 2020-02-26
-$256.00K
derived: sum of 3 quarters · filed 2020-02-26
-$330.00K
derived: sum of 4 quarters · filed 2020-02-26
2017-12-31-$161.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$68.00K
derived: sum of 2 quarters · filed 2020-02-26
-$142.00K
derived: sum of 3 quarters · filed 2020-02-26
-$682.00K
10-K · filed 2020-02-26
2017-09-30$93.00K
10-Q · filed 2018-11-07
$19.00K
derived: sum of 2 quarters · filed 2018-11-07
-$521.00K
10-Q · filed 2018-11-07
-$1.41M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30-$74.00K
10-Q · filed 2018-08-08
-$613.00K
10-Q · filed 2018-08-08
-$1.50M
derived: sum of 3 quarters · filed 2019-02-27
-$1.17M
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31-$539.00K
10-Q · filed 2018-05-08
-$1.43M
derived: sum of 2 quarters · filed 2019-02-27
-$1.09M
derived: sum of 3 quarters · filed 2019-02-27
-$847.00K
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31-$886.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
-$554.00K
derived: sum of 2 quarters · filed 2019-02-27
-$308.00K
derived: sum of 3 quarters · filed 2019-02-27
$686.00K
10-K · filed 2019-02-27
2016-09-30$332.00K
10-Q · filed 2017-11-08
$578.00K
derived: sum of 2 quarters · filed 2017-11-08
$1.57M
10-Q · filed 2017-11-08
$879.00K
derived: sum of 4 quarters · filed 2018-03-06
2016-06-30$246.00K
10-Q · filed 2017-08-08
$1.24M
10-Q · filed 2017-08-08
$547.00K
derived: sum of 3 quarters · filed 2018-03-06
$521.00K
derived: sum of 4 quarters · filed 2018-03-06
2016-03-31$994.00K
10-Q · filed 2017-05-09
$301.00K
derived: sum of 2 quarters · filed 2018-03-06
$275.00K
derived: sum of 3 quarters · filed 2018-03-06
2015-12-31-$693.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06
-$719.00K
derived: sum of 2 quarters · filed 2018-03-06
-$719.00K
10-K · filed 2018-03-06
2015-09-30-$26.00K
10-Q · filed 2016-11-09
-$26.00K
10-Q · filed 2016-11-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Entera Bio Ltd. (ENTX)$0.485B
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Zura Bio Ltd (ZURA)$0.398B-6.56
Surrozen, Inc./DE (SRZN)United States$0.395B